Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications

Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications

US Patent 6733993 · Granted May 11, 2004

Estimated economic value: $119,559,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for use in treatment of acne2025
RSV RNA vaccines2025
Genetic loci associated with rust resistance in soybeans2025
Heat reflection light valve of LCD projector and projector2025
Projector with thermal superconducting material for heat dissipation2025
Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-2025
Micro-display optical engine and projector2025
Systems and methods for providing lighting using modular heat sink structures an2025
Lipid nanoparticles for delivering mRNA vaccines2025
Stabilized RSV F proteins and uses thereof2025
Tuberculosis antigen cassettes2024
Meningococcal B recombinant vaccine2024